Algernon Pharmaceuticals Inc.
AGNPF
$0.0488
-$0.0022-4.31%
OTC PK
| 02/28/2025 | 11/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.34% | -7.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.35% | -7.36% | |||
| Operating Income | 6.35% | 7.36% | |||
| Income Before Tax | 6.10% | 9.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.10% | 9.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.10% | 9.98% | |||
| EBIT | 6.35% | 7.36% | |||
| EBITDA | 6.53% | 7.51% | |||
| EPS Basic | 5.94% | 23.48% | |||
| Normalized Basic EPS | 4.76% | 86.15% | |||
| EPS Diluted | 5.94% | 23.48% | |||
| Normalized Diluted EPS | 4.76% | 86.15% | |||
| Average Basic Shares Outstanding | 0.00% | 16.73% | |||
| Average Diluted Shares Outstanding | 0.00% | 16.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||